MedGenome acquires Illumina’s NovaSeq X Plus and Launches Genome Sequencing Test KaryoSeq

Becomes the first company to bring Illumina’s revolutionary Genome Sequencing Technology to South Asia Launches KaryoSeq to detect genome abnormalities in Prenatal and newborn conditions FOSTER CITY, Calif., July 11, 2023 /PRNewswire/ — MedGenome, a leading global Genomic Diagnostic and…